Profiel
Bradley Stewart Hubbard is currently the Chief Medical Officer at Shanghai Bio-Heart Biological Technology Co., Ltd. He previously worked as the Chief Executive Officer at West Point Technology Chengdu Biotechnology Co. Ltd., Managing Director at Gateway Medical Innovation Center, Manager-Preclinical Research at Guidant Corp., and General Manager at Surpass-Silicon Valley LLC.
Dr. Hubbard received his undergraduate degree in 1980 and his doctorate in 1984 from the University of Missouri.
Actieve functies van Bradley Stewart Hubbard
| Bedrijven | Functie | Begin |
|---|---|---|
| SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD. | Hoofd Techniek/Wetenschap/O&O | 01-03-2021 |
Eerdere bekende functies van Bradley Stewart Hubbard
| Bedrijven | Functie | Einde |
|---|---|---|
West Point Technology Chengdu Biotechnology Co. Ltd. | Algemeen Directeur | 01-02-2019 |
Gateway Medical Innovation Center | Corporate Officer/Principal | 01-01-2018 |
Surpass-Silicon Valley LLC | Algemeen Directeur | 01-12-2009 |
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Corporate Officer/Principal | 01-10-2001 |
Opleiding van Bradley Stewart Hubbard
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
University of Missouri
University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Bio-Heart Biological Technology Co., Ltd.
Shanghai Bio-Heart Biological Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops drug eluting bioresorbable coronary stent systems | Commercial Services |
Surpass-Silicon Valley LLC | |
Gateway Medical Innovation Center | |
West Point Technology Chengdu Biotechnology Co. Ltd. |
















